KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Sep 30, 2026 >>  ABB India 6753.55  [ -1.34% ]  ACC 1204.65  [ 0.01% ]  Ambuja Cements 372.15  [ 1.40% ]  Asian Paints 2413.25  [ -0.05% ]  Axis Bank 1226  [ 1.41% ]  Bajaj Auto 10860  [ 0.38% ]  Bank of Baroda 231  [ 1.45% ]  Bharti Airtel 1758.15  [ -1.01% ]  Bharat Heavy 415  [ 0.39% ]  Bharat Petroleum 303  [ 1.00% ]  Britannia Industries 4810.9  [ -0.37% ]  Cipla 1350  [ -2.39% ]  Coal India 424.35  [ -0.07% ]  Colgate Palm 1774  [ -1.44% ]  Dabur India 381  [ 0.25% ]  DLF 672  [ 1.82% ]  Dr. Reddy's Lab. 1236  [ -1.12% ]  GAIL (India) 170.7  [ 0.41% ]  Grasim Industries 3067.5  [ -1.05% ]  HCL Technologies 1229  [ 0.33% ]  HDFC Bank 709.7  [ -1.43% ]  Hero MotoCorp 5236.65  [ 1.85% ]  Hindustan Unilever 1881.75  [ 0.79% ]  Hindalco Industries 942.3  [ -1.70% ]  ICICI Bank 1322.5  [ 2.31% ]  Indian Hotels Co. 729  [ 2.04% ]  IndusInd Bank 897.7  [ 1.44% ]  Infosys 995  [ -1.04% ]  ITC 263.75  [ -0.47% ]  Jindal Steel 1132  [ 0.22% ]  Kotak Mahindra Bank 417.6  [ 2.86% ]  L&T 3755.1  [ 0.11% ]  Lupin 2042  [ -0.87% ]  Mahi. & Mahi 2947.4  [ -0.12% ]  Maruti Suzuki India 11949  [ 0.42% ]  MTNL 23.02  [ -0.78% ]  Nestle India 1312  [ -1.80% ]  NIIT 85.85  [ -0.41% ]  NMDC 76.79  [ -0.47% ]  NTPC 322  [ -0.60% ]  ONGC 225  [ -2.17% ]  Punj. NationlBak 113.4  [ 0.62% ]  Power Grid Corpn. 260.45  [ -0.21% ]  Reliance Industries 1187.5  [ 0.30% ]  SBI 960.7  [ -0.39% ]  Vedanta 258.9  [ -0.04% ]  Shipping Corpn. 270.5  [ -0.73% ]  Sun Pharmaceutical 1820  [ -2.15% ]  Tata Chemicals 611.2  [ -0.57% ]  Tata Consumer 953  [ -1.45% ]  Tata Motors Passenge 284.85  [ 1.39% ]  Tata Steel 184.65  [ -1.76% ]  Tata Power Co. 359  [ 0.28% ]  Tata Consult. Serv. 2050  [ 0.69% ]  Tech Mahindra 1532.85  [ 0.82% ]  UltraTech Cement 10975  [ 1.18% ]  United Spirits 1350  [ -1.10% ]  Wipro 158.4  [ 0.89% ]  Zee Entertainment 74.49  [ 0.65% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    GUJARAT TERCE LABORATORIES LTD.

    30 September 2026 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE499G01013 BSE Code / NSE Code 524314 / GUJTERC Book Value (Rs.) 12.37 Face Value 10.00
    Bookclosure 25/08/2023 52Week High 60 EPS 2.97 P/E 12.16
    Market Cap. 26.78 Cr. 52Week Low 29 P/BV / Div Yield (%) 2.92 / 0.00 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Gujarat Terce Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202606(3) 202603(3) 202606(3) 202603(3)
    OprtIncome Gujarat Terce Laboratories Ltd. 9.00 11.40 Aarey Drugs & Pharmaceuticals Ltd. 44.63 189.47
    OtherRecurrInc Gujarat Terce Laboratories Ltd. 0.48 0.08 Aarey Drugs & Pharmaceuticals Ltd. 1.72 -0.43
    Operating profit Gujarat Terce Laboratories Ltd. -0.60 0.61 Aarey Drugs & Pharmaceuticals Ltd. 0.48 3.49
    GrossProfit Gujarat Terce Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Gujarat Terce Laboratories Ltd. -0.18 0.10 Aarey Drugs & Pharmaceuticals Ltd. 1.02 1.56
    Equity Capital Gujarat Terce Laboratories Ltd. 7.79 7.79 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Gujarat Terce Laboratories Ltd. -6.65 5.32 Aarey Drugs & Pharmaceuticals Ltd. 1.06 1.84
    GPM Gujarat Terce Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Gujarat Terce Laboratories Ltd. -1.97 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.29 0.82

    Annual Trends

    Gujarat Terce Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Gujarat Terce Laboratories Ltd. 47.47 50.20 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Gujarat Terce Laboratories Ltd. 3.75 3.88 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Gujarat Terce Laboratories Ltd. 0.34 0.31 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Gujarat Terce Laboratories Ltd. 3.49 3.39 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Gujarat Terce Laboratories Ltd. 2.20 -0.98 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Gujarat Terce Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Gujarat Terce Laboratories Ltd. 7.79 7.42 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Gujarat Terce Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Gujarat Terce Laboratories Ltd. 1.94 -1.29 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Gujarat Terce Laboratories Ltd. 1.30 0.94 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Gujarat Terce Laboratories Ltd. 13.53 15.41 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Gujarat Terce Laboratories Ltd. 3.25 3.65 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Gujarat Terce Laboratories Ltd. 1.35 0.52 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Gujarat Terce Laboratories Ltd. 19.95 18.66 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Gujarat Terce Laboratories Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Gujarat Terce Laboratories Ltd. 7.89 7.73 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Gujarat Terce Laboratories Ltd. 4.63 -1.94 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Gujarat Terce Laboratories Ltd. 2.83 -1.32 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Gujarat Terce Laboratories Ltd. 22.63 -15.97 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Gujarat Terce Laboratories Ltd. 0.13 0.15 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Gujarat Terce Laboratories Ltd. 22.78 10.09 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Gujarat Terce Laboratories Ltd. 1.47 1.21 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Gujarat Terce Laboratories Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute